NanoViricides Has Filed its Quarterly Report
Accesswire
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine..
WHO Warns 'Disease X' , Could Be 20 Times Worse , Than COVID-19 Pandemic.
'The Hill' reports that the World Health..